Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2016

Nov 17, 2016

30071_dirs_2016-11-17_ad19150d-7b2b-4122-947b-80dc7d149495.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-11-16

Reporting Person: Sandercock Brett (Chief Financial Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-11-16 ResMed Common Stock Options $57.76 A 40736 Acquired 2023-11-16 ResMed Common Stock (40736) Direct

Holdings (Non-Derivative)

Security Shares Ownership
ResMed Common Stock 66533 Direct

Footnotes

F1: Includes 207 shares of ResMed stock purchased on 10/31/2016, through the ResMed Employee Stock Purchase Plan.

F2: Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2017, 2018 and 2019.